Fernandez Jennifer M, Madsen Steven, Krase Jeffrey M, Shi Vivian Y
College of Medicine, University of Arizona, Tucson, Arizona, USA.
Department of Dermatology, University of Connecticut, Storrs, Connecticut, USA.
Dermatol Ther. 2020 Mar;33(2):e13240. doi: 10.1111/dth.13240. Epub 2020 Feb 10.
Injection site reactions with biologic medications are encountered with variable frequency. Although there is no clear definition, they commonly manifest with pain and irritation at the injection site. Previously proposed reaction classification systems may be impractical or insufficient, and more intuitive nomenclature may benefit clinical dermatologists and patients. Negative injection experiences (NIE) are common reasons for biologic medication nonadherence. Here we provide clinical classifications and recommendations for mitigating these reactions. We categorized NIEs into the following: (a) physical, due to the needle and injection process, (b) irritant, related to properties of the injected solution, and (c) allergic, both immediate and delayed.
生物药物注射部位反应的发生频率各不相同。虽然目前尚无明确的定义,但它们通常表现为注射部位的疼痛和刺激。先前提出的反应分类系统可能不实用或不够完善,更直观的命名法可能会使临床皮肤科医生和患者受益。负面注射体验(NIE)是生物药物治疗中断的常见原因。在此,我们提供了减轻这些反应的临床分类和建议。我们将NIE分为以下几类:(a)物理性的,由针头和注射过程引起;(b)刺激性的,与注射溶液的性质有关;(c)过敏性的,包括速发型和迟发型。